Effect of HBOT on Femoral Head Avascular Necrosis (AVN)
NCT: NCT06931301 · NOT_YET_RECRUITING
Brief Summary
The primary objective of this study is to determine whether the Hyperbaric Oxygen Therapy (HBOT) conducted under the Marx Protocol improves pain outcomes when combined with core decompression with autologous bone marrow aspirate concentrate to treat patients with femoral head avascular necrosis.
Frequently Asked Questions
What is Effect of HBOT on Femoral Head Avascular Necrosis (AVN)?
Effect of HBOT on Femoral Head Avascular Necrosis (AVN) is a clinical trial registered under NCT06931301. Current status: NOT_YET_RECRUITING.
What is the status of NCT06931301?
The current status of NCT06931301 (Effect of HBOT on Femoral Head Avascular Necrosis (AVN)) is: NOT_YET_RECRUITING.
When did Effect of HBOT on Femoral Head Avascular Necrosis (AVN) start?
Effect of HBOT on Femoral Head Avascular Necrosis (AVN) started on 2026-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.